Detalles de la búsqueda
1.
Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trialsâ©.
Int J Clin Pharmacol Ther
; 54(11): 847-855, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27719744
2.
Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
PLoS One
; 16(4): e0250475, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852647
3.
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions.
Clin Park Relat Disord
; 5: 100115, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34888518
4.
Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
PLoS One
; 16(2): e0245827, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33524060
5.
AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles.
J Clin Mov Disord
; 7: 8, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32884828
6.
Octagam® for chronic inflammatory demyelinating polyneuropathy: results from three observational studies.
Neurodegener Dis Manag
; 8(4): 227-231, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29517417
7.
Tolerability and safety of the intravenous immunoglobulin octagam® 10% in patients with immune thrombocytopenia: a post-authorisation safety analysis of two non-interventional phase IV trials.
Hematology
; 23(4): 242-247, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020871
8.
Non-antisense cellular responses to oligonucleotides.
FEBS Lett
; 510(3): 175-80, 2002 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-11801249
9.
Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics.
J Neuroimmunol
; 277(1-2): 145-52, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25454729
10.
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial.
Lancet Neurol
; 12(3): 233-43, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23375965
Resultados
1 -
10
de 10
1
Próxima >
>>